177Lu-LNC1011 in Patients with Metastatic Castration-resistant Prostate Cancer
NCT06250244
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Castration-resistant Prostate Cancer
Interventions
DRUG:
177Lu-LNC1011
Sponsor
Peking Union Medical College Hospital